West Pharmaceutical Services (WST) Interest Expenses (2009 - 2026)
West Pharmaceutical Services (WST) posted quarterly Interest Expenses of $134.9 million for Q2 2026, up 134800.0% year-on-year from N/an in Q2 2025, and down 3.85% on a QoQ basis from $140.3 million in Q1 2026.
West Pharmaceutical Services (WST) Interest Expenses (2009 - 2026) Analysis & Trends
West Pharmaceutical Services (WST) has reported Interest Expenses for 18 consecutive years, with $134.9 million the latest figure, recorded in Q2 2026.
- Quarterly Interest Expenses rose 134800.0% year-over-year to $134.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $134.9 million (up 799.33% YoY) and the FY2025 annual result came in at $146.4 million, up 350.46% from the prior year.
- Interest Expenses declined to $134.9 million in Q2 2026 per WST's latest filing, from $140.3 million in the prior quarter.
- Over the last five years, Interest Expenses for WST reached as high as $140.3 million in Q1 2026 and fell as low as -$800000.0 in Q4 2024.
- A 5-year average of $32.4 million and a median of $5.1 million in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2024 — Interest Expenses plunged 105.37% — and 2026, when it jumped 134800.0%.
- Year by year, Interest Expenses stood at $7.1 million in 2022, then soared by 109.86% to $14.9 million in 2023, then tumbled by 105.37% to -$800000.0 in 2024, then jumped by 3025.0% to $23.4 million in 2025, then jumped by 476.5% to $134.9 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $134.9 million, $140.3 million, and $23.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -52.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 29.10 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 149.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 701.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 6.53 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 134.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 161.60 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 207.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 10.50 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | -12.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 134.90 Mn |
| Jun 30, 2026 | 134.90 Mn |
| Mar 31, 2026 | 140.30 Mn |
| Mar 31, 2026 | 140.30 Mn |
| Dec 31, 2025 | 23.40 Mn |
| Dec 31, 2025 | 23.40 Mn |
| Sep 30, 2025 | 106.90 Mn |
| Sep 30, 2025 | 106.90 Mn |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 113.70 Mn |
| Mar 31, 2025 | 113.70 Mn |
| Dec 31, 2024 | -800,000.00 |
| Dec 31, 2024 | -800,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 15.00 Mn |
| Jun 30, 2024 | 15.00 Mn |
| Mar 31, 2024 | 5.30 Mn |
| Mar 31, 2024 | 5.30 Mn |